The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 20 January 2009, www.theannals.com, DOI 10.1345/aph.1L492.
 The Annals of Pharmacotherapy: Vol. 43, No. 2, pp. 356-359. DOI 10.1345/aph.1L492
© 2009 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borja-Hart, N. L
Right arrow Articles by Christensen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borja-Hart, N. L
Right arrow Articles by Christensen, C.

La Tolérance du Vaccin Papillomavirus Humain chez les Patients Pédiatriques: une Evaluation du Vaccin Adverse Event Reporting System (VAERS)

NL Borja-Hart, S Benavides, et C Christensen

Ann Pharmacother 2009;43:356-9.

Résumé structuré: De récents rapports d'informations ont établi un lien entre le vaccin papillomavirus humain (HPV) et les effets secondaires chez les enfants et les adolescents. La base de données VAERS a été utilisée pour extraire des effets secondaires post-marketing rapportés chez les patients qui ont reçu le vaccin HPV. Depuis l'approbation du vaccin HPV aux Etats-Unis, les enfants et les adolescents âgés de 6–17 ans ont eu 3174 effets secondaires rapportés au VAERS. Parmi ces effets secondaires, 191 (6%) ont été considérés comme sérieux. Bien que ces effets secondaires sont d'une préoccupation significative, de plus amples recherches sont nécessaires avant que les effets secondaires puissent être directement mis en corrélation avec le vaccin.

Traduit par Thierry Youmbi

www.theannals.com, DOI 10.1345/aph.1L492



This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borja-Hart, N. L
Right arrow Articles by Christensen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borja-Hart, N. L
Right arrow Articles by Christensen, C.

homecopy help contact us subscription past issues search current issue
Copyright © 2009 by Harvey Whitney Books Company.